Lipophilic antioxidants in patients with phenylketonuria

American Journal of Clinical Nutrition

Volumn 77, Issue 1, 2003, Pages 185-188

  Colomé, Catrina ^a   Artuch, Rafael ^a,b   Vilaseca, Maria Antònia ^a   Sierra, Cristina ^a   Brandi, Núria ^a   Lambruschini, Nilo ^a   Cambra, Francisco J ^a   Campistol, Jaume ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Section of Gastroenterology   (Spain)

Author keywords

Lipid peroxidation; Lipophilic antioxidants; Malondialdehyde; Oxidative stress; Phenylketonuria; Tocopherol; Ubiquinone 10

Indexed keywords

ANTIOXIDANT; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; RETINOL; SELENIUM; TOCOPHEROL; UBIDECARENONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; ELECTROCHEMICAL DETECTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERPHENYLALANINEMIA; LIPID PEROXIDATION; LIPOPHILICITY; MAJOR CLINICAL STUDY; MALE; PHENYLKETONURIA;

EID: 0037214159     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/77.1.185     Document Type: Article

References (22)

1. Scriver CR, Kaufman, Eisensmith RC, Woo SLC. The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. 7th Ed. New York: McGraw Hill, 1995:1015-75.
2. Przyrembel H, Bremer HJ. Nutrition, physical growth, and bone density in treated phenylketonuria. Eur J Pediatr 2000;159(suppl):S129-35.
3. Acosta PB, Yannicelli S. Plasma micronutrient concentrations in infants undergoing therapy for phenylketonuria. Biol Trace Elem Res 1999;67:75-84.
4. Van Bakel MM, Printzen G, Wermuth B, Wiesmann UN. Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am J Clin Nutr 2000;72:976-81.
5. Sierra C, Vilaseca MA, Moyano D, et al. Antioxidant status in hyperphenylalaninemia. Clin Chim Acta 1998;276:1-9.
6. Wilke BC, Vidailhet M, Favier A, et al. Selenium glutathione peroxidase (GSH-Px) and lipid peroxidation products before and after selenium supplementation. Clin Chim Acta 1992;207:137-42.
7. Darling G, Mathias P, O'Regan M, Naughten E. Serum selenium levels in individuals on PKU diets. J Inherit Metab Dis 1992;15:769-73.
8. Artuch R, Vilaseca MA, Moreno J, Lambruschini N, Cambra FJ, Campistol J. Decreased serum ubiquinone-10 concentration in phenylketonuria. Am J Clin Nutr 1999;70:892-5.
9. Artuch R, Colomé C, Vilaseca MA, et al. Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria. J Inherit Metab Dis 2001;24:359-66.
10. Castillo M, Zafra MF, Garcfa-Peregrfn E. Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia. Neurochem Res 1988;13:551-5.
11. Shefer S, Tint GS, Jean-Guillaume D, et al. Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse? J Neurosci Res 2000;61:549-63.
12. Finckh B, Kontush A, Commentz J, Hübner C, Burdelski M, Kohlschútter A. Monitoring of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma microsamples using high-performance liquid chromatography with coulometric electrochemical detection. Anal Biochem 1995:232:210-6.
13. Sierra C, Pastor MC, de Ramon M. Liquid chromatography determination of α-tocopherol in erythrocytes. Clin Chim Acta 1992;208:119-26.
14. Badcock NR, Zoanetti GD, Martin ES. Nonchromatographic assay for malondialdehyde-thiobarbituric acid with HPLC equivalence. Clin Chem 1997;43:1655-7.
15. Lee W, Roberts SM, Labbe RF. Ascorbic acid determination with an automated enzymatic procedure. Clin Chem 1997;43:154-7.
16. Lloyd B, Holt P, Delves HT. Determination of selenium in biological samples by absorption spectroscopy. Analyst 1982;107:927-33.
17. Plagia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-69.
18. Acosta PB. Nutrition studies in treated infants and children with phenylketonuria: Vitamins, minerals, trace elements. Eur J Pediatr 1996;155:136-9.
19. Moyano D, Vilaseca MA, Pineda M, et al. Tocopherol in inborn errors of intermediary metabolism. Clin Chim Acta 1997;263:147-55.
20. Thomas SR, Neuzil J, Stocker R. Inhibition of LDL oxidation by ubiquinol-10. A prospective mechanism for coenzyme Q in atherogenesis? Mol Aspects Med 1997;18:85-103.
21. Noack H, Kube U, Augustin W. Relations between tocopherol depletion and coenzyme Q during lipid peroxidation in rat liver mitochondria. Free Radic Res 1994;20:375-86.
22. Halliwell B. Antioxidant defence mechanisms: From the beginning to the end (of the beginning). Free Radic Res 1999;31:261-72.